Related Experiment Videos
Do we need prognostic factors in nodal-negative breast cancer? Arbiter
1Lombardi Cancer Center, Georgetown University Medical Center, NRB E504, Washington, DC 20007, USA. hayesdf@gunet.georgetown.edu
European Journal of Cancer (Oxford, England : 1990)
|March 10, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).
Annals of oncology : official journal of the European Society for Medical Oncology·2018
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
Breast cancer research and treatment·2017
Epithelial Cell Adhesion Molecule Expression in Canine Tumours.
Journal of comparative pathology·2016
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
European journal of cancer (Oxford, England : 1990)·2026
Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.
European journal of cancer (Oxford, England : 1990)·2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
European journal of cancer (Oxford, England : 1990)·2026
Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.
European journal of cancer (Oxford, England : 1990)·2026
Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.
European journal of cancer (Oxford, England : 1990)·2026
COVID-19 Vaccination and Risk of Post-COVID-19 Cardiovascular Disease: A Population-Based Cohort and Target Trial Emulation Study.
European heart journal. Quality of care & clinical outcomes·2026
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.
JAMA internal medicine·2026